In 2016 the ACT committed to scoping and designing a Drug and Alcohol Court (DAC).
NDARC has been invited to undertake research in partnership with NSW Aboriginal drug and alcohol Residential Rehabilitation Services. This research is unique in being embedded into the routine delivery of their services.
Alcohol and other drug (AOD) treatment is key for improving health and reducing the social impact of AOD use. However, the treatment itself is not the only variable that impacts on whether health outcomes are improved.
To reduce alcohol related harms, the World Health Organisation recommends regulating the sale and supply of alcohol, including limiting the number of premises selling alcohol as well as the hours during which alcohol can be sold.
This project seeks to develop knowledge about effective models of partnership between rural Aboriginal communities and researchers across a range of community-led programs delivered from 2012-2016, which aimed to reduce drug and alcohol-related harm.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
The monograph is an outcome of the Intergovernmental Committee on Drugs (IGCD) Fetal Alcohol Spectrum Disorder (FASD) Working Party.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
The IDAT Program, established under the Drug and Alcohol Treatment Act 2007 of New South Wales, aims to “provide short-term care, with an involuntary supervised withdrawal component, to protect the health and safety of people with severe substance dependence who have experienced, or are at risk o